Skip to main content

Table 2 Quantity and function of OB cultured with CCL3 and anti-CCL3

From: Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease

 

Number of cases

Number of cells (105/ml)

Number of mineralized nodules (/HPF)

OCN (μg/L)

Blank

21

2.82 ± 0.19

9.35 ± 0.62

803.375 ± 40.654

CCL3

21

2.42 ± 0.22

5.42 ± 0.39*

750.643 ± 41.116**

Anti-CCL3

21

2.49 ± 1.23

6.88 ± 1.75

787.358 ± 32.063#

  1. *Significantly lower than that in the blank group. **Significantly lower than that in the blank group. #Significantly higher than that in the CCL3 group.